Skip to main content
. 2022 Sep 14;13:975233. doi: 10.3389/fimmu.2022.975233

Figure 4.

Figure 4

(A) Western blot for cleavage of the effector of the apoptosis Poly (ADP-ribose) polymerase (PARP), or FKBP12 endogenous control. (B) Histogram depicting viable ΔiC8-RQR8/Rapa.ΔiC9-ΔCD19 Jurkat cells after administering the BB homodimerizer, sirolimus (siro) or both in the absence or presence of the ZVAD fmk pan-caspases inhibitor.